Confirmed Biallelic RPE65 Mutation-associated Retinal Dystrophy
1 clinical trials · Condition
◉ Watch Confirmed Biallelic RPE65 Mutation-associated Retinal Dystrophy
| Record | Firm | Date |
|---|---|---|
| A Patient Registry Study for Patients Treated With Voretigene Neparvovec in US (NCT03597399) | Spark Therapeutics, Inc. | 2019-01-10 |
Track Confirmed Biallelic RPE65 Mutation-associated Retinal Dystrophy automatically
Every clearance here is in the API, with alerts when new ones post.